- $180.64m
- $85.59m
- $623.08m
- 57
- 68
- 33
- 52
2020 February 1st | 2021 January 30th | 2022 January 29th | 2023 January 28th | 2024 February 3rd | |
---|---|---|---|---|---|
Period Length: | 52 W | 52 W | 52 W | 52 W | 53 W |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 619 | 531 | 776 | 672 | 623 |
Cost of Revenue | |||||
Gross Profit | 187 | 142 | 277 | 203 | 166 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 591 | 534 | 688 | 661 | 654 |
Operating Profit | 28.5 | -3.04 | 87.6 | 11.2 | -31 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 31.4 | -2.46 | 87 | 13.2 | -25.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 22.6 | -1.15 | 64.2 | 9.68 | -34.5 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 22.6 | -1.15 | 64.2 | 9.68 | -34.5 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 22.6 | -1.15 | 64.2 | 9.68 | -34.5 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.767 | -0.017 | 2.07 | 0.32 | -1.08 |
Special Dividends per Share |